“Helping to stop the spread of chytrid is a necessity to ensure healthy ecosystems globally,” said Colossal Foundation Director Matt James. “This isn’t optional. We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come."
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
Colossal says its efforts could help boost "the U.S. high-tech advantage." Its gene editing technologies "will make waves across sectors—in agriculture with new biofuels and preserving biodiversity, as well as in human health through improved gene therapy and vaccine development," the company said.
Irving-based Celanese Corp., a specialty materials and chemical company, has teamed up with Hong Kong-based VIGOR Precision Ltd., a manufacturer of plastic gears, to develop lightweight plastic joints for humanoid robots....
Irving-based Celanese Corp., a specialty materials and chemical company, has teamed up with Hong Kong-based VIGOR Precision Ltd., a manufacturer of plastic gears, to develop lightweight plastic joints for humanoid robots....